Friend or foe? IFNλ drives fibrosis.
Author:
- 6 July 2026
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 223 (8)
Abstract
Type III IFNs, or IFNλ, are pleiotropic immune mediators that mostly work at mucosal surfaces by signaling in epithelial cells and selected immune cells. Zhou, Zhang, and colleagues (https://doi.org/10.1084/jem.20251858) demonstrate that IFNλ also signals in kidney fibroblasts sustaining renal fibrosis.Keywords
This publication has 16 references indexed in Scilit:
- Interferon-λ drives renal fibrosis by coordinating epithelial-fibroblast crosstalk.Journal of Experimental Medicine, 2026
- Interferons in health and diseaseCell, 2025
- Type III interferons induce pyroptosis in gut epithelial cells and impair mucosal repairCell, 2024
- In search of a function for human type III interferons: insights from inherited and acquired deficitsCurrent Opinion in Immunology, 2024
- The interferon landscape along the respiratory tract impacts the severity of COVID-19Cell, 2021
- Type I and III interferons disrupt lung epithelial repair during recovery from viral infectionScience, 2020
- IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil functionNature Immunology, 2017
- Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host FitnessImmunity, 2017
- IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β productionJournal of Experimental Medicine, 2015
- Diverse intracellular pathogens activate type III interferon expression from peroxisomesNature Immunology, 2014